Introduction: Vitiligo, a skin disorder affecting melanocytes, poses treatment challenges. There is a need to investigate the role of Tacrolimus in pediatric cases for its efficacy and safety. The pre
This repository contains the supplementary material accompanying the above article. The material provides expanded methodological detail and additional descriptive analyses that support, but are not e
Supplementary Figure 1 (Figure 2) shows the percentage of improvement in facial VASI scores over treatment time for all patients. Supplementary Figure 2 (Figure 3) shows the percentage of improvement
Supplementary Figure 1 (Figure 2) shows the percentage of improvement in facial VASI scores over treatment time for all patients. Supplementary Figure 2 (Figure 3) shows the percentage of improvement
Supplementary Figure 1 (Figure 2) shows the percentage of improvement in facial VASI scores over treatment time for all patients. Supplementary Figure 2 (Figure 3) shows the percentage of improvement
